[The pediatric-to-adult transit clinic as a quality-securing measure in endocrinological diseases]

A Grüters1

  • 1Zentrum für Kinderheilkunde und Jugendmedizin Charité Berlin. annette.grueters@charite.de

Insights

Structured transit clinics are crucial for pediatric patients with endocrinological diseases transitioning to adulthood. This ensures continuity of care and leverages pediatric expertise for better adult outcomes.

Area of Science:

  • Pediatric Endocrinology
  • Transition Medicine
  • Healthcare Quality Management

Background:

  • Pediatric endocrinology care has advanced significantly in the last 20 years, improving life expectancy and quality of life for chronic endocrine conditions.
  • A lack of long-term data and experience exists for adult outcomes due to the relatively recent improvements in pediatric care.

Purpose of the Study:

  • To highlight the necessity of structured transit clinics for pediatric endocrinology patients.
  • To ensure the continuity and quality of care as patients transition from pediatric to adult healthcare systems.
  • To adapt successful pediatric care models for adult endocrinology patients.

Main Methods:

  • Leveraging existing pediatric care experience and results.
  • Adapting pediatric care protocols to meet the specific needs of adult patients.
  • Implementing joint medical counseling and care services.
  • Continuing the utilization of non-medical pediatric support services.

Main Results:

  • Structured transit clinics are essential for maintaining high-quality care standards.
  • Adaptation of pediatric care models is necessary for successful transition.
  • Additional resources are required for effective transition services, including joint counseling and non-medical support.

Conclusions:

  • Structured transit clinics are a prerequisite for quality care in adult endocrinology.
  • The German Health Care Modernization Act (Gesundheitsmodernisierungsgesetz, GMG) provides a basis for implementing these models.
  • Rapid implementation of these structures is vital for quality control and improved patient outcomes.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...